P

Inventor

EISEN HERMAN N

US14 patents
⚠️ This page may combine multiple inventors who share the name “EISEN HERMAN N”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MASSACHUSETTS INST TECHNOLOGY

12 patents
US4933185AJun 12, 1990

System for controlled release of biologically active compounds

MASSACHUSETTS INST TECHNOLOGY161 citations98
US4921757AMay 1, 1990

System for delayed and pulsed release of biologically active substances

MASSACHUSETTS INST TECHNOLOGY326 citations98
US4900556AFeb 13, 1990

System for delayed and pulsed release of biologically active substances

MASSACHUSETTS INST TECHNOLOGY151 citations98
US4543439ASep 24, 1985

Production and use of monoclonal antibodies to phosphotyrosine-containing proteins

MASSACHUSETTS INST TECHNOLOGY272 citations96
US5189147AFeb 23, 1993

Meterodimeric T lymphocyte receptor antibody

MASSACHUSETTS INST TECHNOLOGY54 citations95
US4874845AOct 17, 1989

T lymphocyte receptor subunit

MASSACHUSETTS INST TECHNOLOGY34 citations92
US5882945AMar 16, 1999

Heterodimeric T lymphocyte receptor

MASSACHUSETTS INST TECHNOLOGY6 citations73
US4970296ANov 13, 1990

Heterodimeric T lymphocyte receptor

MASSACHUSETTS INST TECHNOLOGY12 citations73
US4873190AOct 10, 1989

Heterodimeric T lymphocyte receptor

MASSACHUSETTS INST TECHNOLOGY13 citations73
US5977321ANov 2, 1999

Heterodimeric T lymphocyte receptor subunit

MASSACHUSETTS INST TECHNOLOGY5 citations62
US5580961ADec 3, 1996

Heterodimeric T lymphocyte receptor subunit

MASSACHUSETTS INST TECHNOLOGY4 citations62
US4783410ANov 8, 1988

Cytotoxic t lymphocyte serine esterase and method for stimulation and inhibition

MASSACHUSETTS INST TECHNOLOGY5 citations58

WHITEHEAD BIOMEDICAL INST

2 patents
US6875435B2Apr 5, 2005

In vivo CTL elicitation by heat shock protein fusion proteins maps to a discrete domain and is CD4+ T cell-independent

WHITEHEAD BIOMEDICAL INST15 citations88
US7501125B2Mar 10, 2009

Vivo CTL elicitation by heat shock protein fusion proteins maps to a discrete domain and is CD4+ T cell-independent

WHITEHEAD BIOMEDICAL INST0 citations46